Here are seven updates from spine and orthopedic device companies in the last week:
The Latest
Despite the COVID-19 pandemic, Stryker continued financial growth and has posted gains in its spine and neurotechnology segment since 2019. While the orthopedic segment has grown overall since 2019, the increase was most apparent in trauma and extremities sales.
Orthofix has entered into an exclusive license agreement to commercialize Italy-based IGEA's bone, cartilage and soft tissue devices in the U.S. and Canada.
Assure Holdings signed an agreement with Aetna Colorado to perform intraoperative neuromonitoring services as an in-network provider, effective May 1.
A 42-year-old American woman suffering from idiopathic scoliosis traveled to India to undergo a fusionless scoliosis surgery at Apollo Hospitals in Chennai, The Hindu reported April 28.
New developments in 3D-printed implants hold great potential in spine surgery, but custom implants may not take a full grasp on the industry yet, according to Kornelis Poelstra, MD, PhD, a spine surgeon at Las Vegas-based Allegiant Spine Institute.
The global orthopedic market lost billions in revenue since the COVID-19 pandemic began, according to an April 28 GlobalData report.
Stryker's first-quarter sales were up 21.4 percent as the company focuses on closing its acquisition of Wright Medical.
Cincinnati-based UC Health named Michael Archdeacon, MD, the next CEO of its physician group, according to a Cincinnati Business Courier report.
Stryker posted $1.5 billion in first-quarter orthopedics sales, a 21.4 percent increase compared to the first quarter of 2020.